183 related articles for article (PubMed ID: 31725875)
21. Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease.
Jen MH; Saxena S; Bottle A; Aylin P; Pollok RC
Aliment Pharmacol Ther; 2011 Jun; 33(12):1322-31. PubMed ID: 21517920
[TBL] [Abstract][Full Text] [Related]
22. Value of endoscopy and MRI for predicting intestinal surgery in patients with Crohn's disease in the era of biologics.
Jauregui-Amezaga A; Rimola J; Ordás I; Rodríguez S; Ramírez-Morros A; Gallego M; Masamunt MC; Llach J; González-Suárez B; Ricart E; Panés J
Gut; 2015 Sep; 64(9):1397-402. PubMed ID: 25516418
[TBL] [Abstract][Full Text] [Related]
23. Managing Clostridium difficile in inflammatory bowel disease (IBD).
Hashash JG; Binion DG
Curr Gastroenterol Rep; 2014; 16(7):393. PubMed ID: 24838421
[TBL] [Abstract][Full Text] [Related]
24. Impact of Clostridium difficile infection on inflammatory bowel disease outcome: a review.
Trifan A; Stanciu C; Stoica O; Girleanu I; Cojocariu C
World J Gastroenterol; 2014 Sep; 20(33):11736-42. PubMed ID: 25206277
[TBL] [Abstract][Full Text] [Related]
25. Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn's disease.
Strömbeck A; Lasson A; Strid H; Sundin J; Stotzer PO; Simrén M; Magnusson MK; Öhman L
BMC Gastroenterol; 2020 May; 20(1):130. PubMed ID: 32366222
[TBL] [Abstract][Full Text] [Related]
26. Smoking influences the need for surgery in patients with the inflammatory bowel diseases: a systematic review and meta-analysis incorporating disease duration.
Kuenzig ME; Lee SM; Eksteen B; Seow CH; Barnabe C; Panaccione R; Kaplan GG
BMC Gastroenterol; 2016 Dec; 16(1):143. PubMed ID: 28003021
[TBL] [Abstract][Full Text] [Related]
27. Microbiota-associated Risk Factors for Clostridioides difficile Acquisition in Hospitalized Patients: A Prospective, Multicentric Study.
Solbach P; Chhatwal P; Woltemate S; Tacconelli E; Buhl M; Autenrieth IB; Vehreschild MJGT; Jazmati N; Gerhard M; Stein-Thoeringer CK; Rupp J; Ulm K; Ott A; Lasch F; Koch A; Manns MP; Suerbaum S; Bachmann O
Clin Infect Dis; 2021 Nov; 73(9):e2625-e2634. PubMed ID: 32589701
[TBL] [Abstract][Full Text] [Related]
28. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients.
Kelly CR; Ihunnah C; Fischer M; Khoruts A; Surawicz C; Afzali A; Aroniadis O; Barto A; Borody T; Giovanelli A; Gordon S; Gluck M; Hohmann EL; Kao D; Kao JY; McQuillen DP; Mellow M; Rank KM; Rao K; Ray A; Schwartz MA; Singh N; Stollman N; Suskind DL; Vindigni SM; Youngster I; Brandt L
Am J Gastroenterol; 2014 Jul; 109(7):1065-71. PubMed ID: 24890442
[TBL] [Abstract][Full Text] [Related]
29. Increased Rates of Clostridium difficile Infection and Poor Outcomes in Patients with IBD with Cytomegalovirus.
McCurdy JD; Enders FT; Khanna S; Bruining DH; Jones A; Killian JM; Tariq R; Smyrk TC; Loftus EV
Inflamm Bowel Dis; 2016 Nov; 22(11):2688-2693. PubMed ID: 27755270
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcome of surgically treated Crohn's colitis: a prospective study.
Fichera A; McCormack R; Rubin MA; Hurst RD; Michelassi F
Dis Colon Rectum; 2005 May; 48(5):963-9. PubMed ID: 15785882
[TBL] [Abstract][Full Text] [Related]
31. Anastomotic Ulcers After Ileocolic Resection for Crohn's Disease Are Common and Predict Recurrence.
Hirten RP; Ungaro RC; Castaneda D; Lopatin S; Sands BE; Colombel JF; Cohen BL
Inflamm Bowel Dis; 2020 Jun; 26(7):1050-1058. PubMed ID: 31639193
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Disease Phenotypes and Clinical Characteristics Among South Asian and White Patients with Inflammatory Bowel Disease at a Tertiary Referral Center.
Bodiwala V; Marshall T; Das KM; Brant SR; Seril DN
Inflamm Bowel Dis; 2020 Nov; 26(12):1869-1877. PubMed ID: 32144933
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
[TBL] [Abstract][Full Text] [Related]
34. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.
Nitzan O; Elias M; Chazan B; Raz R; Saliba W
World J Gastroenterol; 2013 Nov; 19(43):7577-85. PubMed ID: 24282348
[TBL] [Abstract][Full Text] [Related]
35. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE.
Rodríguez C; Romero E; Garrido-Sanchez L; Alcaín-Martínez G; Andrade RJ; Taminiau B; Daube G; García-Fuentes E
Gut Microbes; 2020 Nov; 12(1):1725220. PubMed ID: 32129694
[TBL] [Abstract][Full Text] [Related]
36. Frequency and risk factors of surgical recurrence of Crohn's disease after primary bowel resection.
Zhou J; Li Y; Gong J; Zhu W
Turk J Gastroenterol; 2018 Nov; 29(6):655-663. PubMed ID: 30381273
[TBL] [Abstract][Full Text] [Related]
37. Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease.
Suskind DL; Brittnacher MJ; Wahbeh G; Shaffer ML; Hayden HS; Qin X; Singh N; Damman CJ; Hager KR; Nielson H; Miller SI
Inflamm Bowel Dis; 2015 Mar; 21(3):556-63. PubMed ID: 25647155
[TBL] [Abstract][Full Text] [Related]
38. The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients.
Roth R; Vavricka S; Scharl M; Schreiner P; Safroneeva E; Greuter T; Zeitz J; Misselwitz B; Schoepfer A; Barry MP; Rogler G; Biedermann L;
United European Gastroenterol J; 2021 Sep; 9(7):773-780. PubMed ID: 34431613
[TBL] [Abstract][Full Text] [Related]
39. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection.
Planche TD; Davies KA; Coen PG; Finney JM; Monahan IM; Morris KA; O'Connor L; Oakley SJ; Pope CF; Wren MW; Shetty NP; Crook DW; Wilcox MH
Lancet Infect Dis; 2013 Nov; 13(11):936-45. PubMed ID: 24007915
[TBL] [Abstract][Full Text] [Related]
40. Oral Omilancor Treatment Ameliorates Clostridioides difficile Infection During IBD Through Novel Immunoregulatory Mechanisms Mediated by LANCL2 Activation.
Tubau-Juni N; Bassaganya-Riera J; Leber AJ; Alva SS; Hontecillas R
Inflamm Bowel Dis; 2024 Jan; 30(1):103-113. PubMed ID: 37436905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
